Wernau Asset Management’s Pfizer PFE Stock Holding History

Wernau Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,500	Closed	-$311K	–	51
2025 Q4	$311K	Sell	12,500 -22,500	-64%	-$567K	0.17%	39
2025 Q3	$892K	Buy	35,000 +15,000	+75%	+$370K	0.61%	24
2025 Q2	$485K	Buy	20,000 +10,000	+100%	+$233K	0.34%	31
2025 Q1	$253K	Buy	10,000 +5,000	+100%	+$131K	0.2%	45
2024 Q4	$133K	Buy	+5,000	New	+$136K	0.1%	50

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wernau Asset Management's PFE Position: Q2 2026 in Review

Wernau Asset Management increased its Pfizer (PFE) stake by 5% in Q2 2026, buying an estimated $149K and bringing the position to 119,725 shares worth $2.88M. The position accounts for 1.5% of the portfolio, ranked #12.

Wernau Asset Management first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.2M in Q1 2025. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Wernau Asset Management held 119,725 shares of Pfizer worth $2.88M as of Q2 2026.
Wernau Asset Management bought 5,694 Pfizer shares in Q2 2026, an estimated $149K.
Pfizer made up 1.5% of Wernau Asset Management's portfolio in Q2 2026, its #12 holding.
Wernau Asset Management first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
Wernau Asset Management's Pfizer position peaked at $4.2M in Q1 2025.
2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Wernau Asset Management's 13F filing for Q2 2026, filed 31 Jul 2026.